Trial intelligence / Profile preview

ANGIOSAFE 1

2015-002930-35Phase 4Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Dec 2015
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 4 trial of liraglutide and metformin in type 2 diabetes mellitus (T2DM), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2015; status: active.

02

Drugs

liraglutidemetformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2015-002930-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002930-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call